- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2662-8651
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Stem cell therapy for COVID-19 pneumonia ; volume:3 ; number:1 ; day:17 ; month:2 ; year:2022 ; pages:1-20 ; date:12.2022
Molecular biomedicine ; 3, Heft 1 (17.2.2022), 1-20, 12.2022
- Creator
-
Kebria, Maziar Malekzadeh
Milan, Peiman Brouki
Peyravian, Noshad
Kiani, Jafar
Khatibi, Soheil
Mozafari, Masoud
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43556-021-00067-8
- URN
-
urn:nbn:de:101:1-2022052118493764807718
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kebria, Maziar Malekzadeh
- Milan, Peiman Brouki
- Peyravian, Noshad
- Kiani, Jafar
- Khatibi, Soheil
- Mozafari, Masoud
- SpringerLink (Online service)
Other Objects (12)
Nebulization Therapy with Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Pneumonia
Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives
Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy
Mesenchymal stem cells as a potential therapy for COVID-19
Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia
Stem cell research & therapy
Stem Cell Therapy for Autism
Stem cell therapy in lupus
Stem cell nebulization therapy for COVID-19 infection: radiological and clinical outcomes
Camostat mesylate therapy in critically ill patients with COVID-19 pneumonia
Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanisms
Stem-cell therapy for neurologic diseases
Nebulization Therapy with Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Pneumonia
Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives
Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy
Mesenchymal stem cells as a potential therapy for COVID-19
Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia
Stem cell research & therapy
Stem Cell Therapy for Autism
Stem cell therapy in lupus
Stem cell nebulization therapy for COVID-19 infection: radiological and clinical outcomes
Camostat mesylate therapy in critically ill patients with COVID-19 pneumonia
Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanisms
Stem-cell therapy for neurologic diseases
Nebulization Therapy with Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Pneumonia
Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives
Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy
Mesenchymal stem cells as a potential therapy for COVID-19
Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia
Stem cell research & therapy
Stem Cell Therapy for Autism
Stem cell therapy in lupus
Stem cell nebulization therapy for COVID-19 infection: radiological and clinical outcomes
Camostat mesylate therapy in critically ill patients with COVID-19 pneumonia
Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanisms